Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03331978 · ClinicalTrials.gov registry record · NA
A Randomized Controlled Trial of an Antiretroviral Treatment Adherence Intervention for HIV+ African Americans
A NA study of HIV/AIDS, sponsored by RAND.
- Completed
- Registry status
- NA
- Development phase
- 306
- Enrollment target
- 1
- Study location
NCT03331978: Completed NA study of HIV/AIDS, sponsored by RAND.
NCT03331978 is a NA study of HIV/AIDS that has completed, run by RAND. The registered enrollment target is 306 participants, below the 33,176-participant average among 61 other HIV/AIDS trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03331978, a NA study of HIV/AIDS, has completed, sponsored by RAND.
- COMPLETED
- Registry status
- NA
- Development phase
- 306 participants
- Enrollment target
- 1
- Study location
Study Summary
Project Rise is a randomized controlled trial (RCT) of an innovative, culturally congruent treatment education (TE) intervention for African Americans with HIV that targets cultural and social issues contributing to health disparities.
Primary Outcome
Percentage of doses taken of those prescribed from electronic monitoring. Here we present all data collected at all time points used in analysis. Evaluation of intervention efficacy was performed with repeated measures regression using continuous adherence measurements at all 6 months post-intervention (7th through 12th month post-baseline) and was restricted to those with adherence data at baseline.
Conditions Studied
Interventions
- BEHAVIORAL Rise - Treatment Education
Study Locations (1)
California
- AIDS Project Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 306 participants |
| Start Date | 2018-01-23 |
| Est. Completion | 2021-11-07 |
| Phase | NA |
What the finished NCT03331978 record still lists
NCT03331978 is an interventional study that assigns participants to a tested intervention. The registered 306 participants enrollment target is mid-sized for trials with a published cap, below the 33,176-participant average among 61 other HIV/AIDS trials with a reported enrollment target (99% lower).
The record links to 1 condition, with HIV/AIDS appearing as the primary indexed condition, and to 1 intervention - of which Rise - Treatment Education is the first listed.
NCT03331978 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03331978 about?
NCT03331978 is a clinical study titled "A Randomized Controlled Trial of an Antiretroviral Treatment Adherence Intervention for HIV+ African Americans". Project Rise is a randomized controlled trial (RCT) of an innovative, culturally congruent treatment education (TE) intervention for African Americans with HIV that targets cultural and social issues contributing to health disparities.
What is the current status of trial NCT03331978?
This trial is currently completed. It is a NA study. The enrollment target is 306 participants. The study started on 2018-01-23. Estimated completion is 2021-11-07.
What conditions does trial NCT03331978 study?
This clinical trial studies the following conditions: HIV/AIDS.
What interventions are being tested in trial NCT03331978?
The interventions under investigation include: Rise - Treatment Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT03331978?
This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03331978 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV/AIDS
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03331978's enrollment target sits among peer trials
306 19th of 61 higher than 43 of 61 other HIV/AIDS trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV/AIDS trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Mobile Gaming App to Improve Adherence to PrEP
RECRUITING · NA
-
LinkPositively+ A Mobile Health App Delivered Intervention to Improve HIV Care Outcomes Among Black Women Affected by Mental Health and Violence
RECRUITING · NA
-
MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM
RECRUITING · NA
-
MyPEEPS LITE Trial
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Improving the Organizational Social Context to Address Structural Racism and Discrimination
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05078970 · 306 participants · NA
Advancing Suicide Intervention Strategies for Teens During High Risk Periods
- NCT05843695 · 306 participants · NA
Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety
- NCT06057337 · 306 participants · NA
Families With Pride ("Familias Con Orgullo").
- NCT06498635 · 306 participants · Phase 3
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI